2019 Half-year consolidated results: Deinove’s progress coming to fruition

NEXT STORY
Annual General Meeting in Oasmia Pharmaceutical AB on September 26, 2019
PREV STORY
Inventiva receives FDA Fast Track designation for lead asset lanifibranor in NASH
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis

AUSTIN, Texas, June 09, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

author_avatar
NASDAQ Market News

Saniona AB: Saniona publicerar sin delårsrapport för det andra kvartalet 2017

PRESSMEDDELANDE 23 augusti 2017 Finansiella nyckeltal Jan - juni 2017 (jan - juni 2016) ...

author_avatar
NASDAQ Market News

Hypophosphatemia Data From AMAG Phase 3 Trial Presented at the American Society of Nephrology

Data Shows Patients Treated with Feraheme® (ferumoxytol) were Less Likely to Develop Severe Hypophosphatemia ...

author_avatar
NASDAQ Market News